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Abstract
Background: Persistent left superior vena cava (PLSVC) is present in about 0.3–0.5% of the 
general population and in about 12% of patients with other abnormalities. This congenital 
anomaly is usually asymptomatic and does not cause any physiological problems. However, it 
may become a significant problem in multiple clinical situations. Various complications related 
to PLVSC are encountered in anesthesiological, nephrological, oncological and cardiological 
procedures. The presence of PLSVC is usually incidentally detected during placement of pace-
maker (PM), implantable cardioverter-defibrillator (ICD) and cardiac resynchronization the-
rapy (CRT) leads. Technical difficulties during lead positioning (especially ventricular leads) 
are commonly known and often described in the literature. The purpose of the present study 
was to evaluate the specific methods used for implantation of increasingly complicated pacing 
systems, finding an optimal strategy in patients with PLSVC, especially with electrotherapy 
complications.
Methods: We performed a single-center retrospective analysis of 11 patients (7 women and  
4 men, mean age 60.4 ± 13 years) with PLSVC hospitalized in single Cardiology Department 
between 2000 and 2012. The clinical characteristic, indications for PM/ICD/CRT implanta-
tion, technique of implantation and complications were evaluated.
Results: In PLSVC patients, different indications for pacing or resynchronization thera-
py were represented: sick sinus syndrome (SSS) in 4 patients, 3rd degree atrio-ventricular 
(AV) block in 4 patients, dilated cardiomyopathy with left bundle branch block in 2 patients, 
dilated cardiomyopathy and non-sustained ventricular tachycardia episodes in 1 patient. 
In patients no. 1, 3, 4 and 10 the complications necessitated the change of leads or type 
of pacing. Transvenous lead extraction was successfully performed in patient no. 1 and  
10 with re-implantation of new leads via PLSVC in patient no. 1 and via right superior vena 
cava in patient no. 10. Patient no. 3 received an additional ventricular lead via PLSVC be-
cause of 2nd degree AV block (formerly atrial lead implanted due to SSS). In patient no. 4 with 
left atrial pacing (lead in coronary sinus), prosthetic mitral valve replacement was combined 
with epicardial ventricular lead placement. Patients no. 2 and 7 received a CRT device, wit-
hout technical problems in patient no. 7, whereas in patient no. 2 due to difficulties with left 
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ventricular lead positioning a hybrid approach to epicardial lead pacing was used. In patient 
no. 8 an ICD was implanted with difficulty in placing defibrillator lead. Patient no. 5 received 
2 atrial leads via PLSVC with successful biatrial pacing; patient no. 6 with the necessity of 
DDD pacing had a (ventricular) lead for left atrial pacing and a typical right ventricular lead. 
In patients no. 9 and 11 typical DDD pacing was used with contralateral placement of the 
leads due to anatomical and technical differences. After 12 years of follow-up the survival is 
90.9%. Late electrotherapy complications have developed only in patient no. 8 (problems with 
the defibrillator lead).
Conclusions: Patients with PLSVC are a very heterogeneous group with different indications 
for pacing, therefore individualization of therapy is required. Technical complications connec-
ted with pacing of the right heart chambers are commonly known, hence transvenous left atrial 
or left ventricular lead implantation should be attempted. In case of difficulties in transvenous 
positioning of the lead, a hybrid or isolated cardiac surgery technique should be considered. Be-
cause of the increasing number of electrotherapy complications, these problems are also present 
in PLSVC patients. Transvenous lead extraction with re-implantation of a pacing system has 
not been reported yet. For this reason a thorough evaluation of the venous system is required in 
PLSVC patients before intervention. (Cardiol J 2014; 21, 2: 128–137)
Key words: persistent left superior vena cava, electrotherapy complications, 
transvenous leads extraction
Introduction
Persistent left superior vena cava (PLSVC) is 
a congenital anomaly found in about 0.3–0.5% of 
the general population and in about 12% of patients 
with other abnormalities [1]. The PLSVC as an 
isolated venous anomaly is usually asymptomatic, 
however, it may become a significant problem 
when using some treatment strategies. Various 
complications related to PLVSC are encountered 
in anesthesiological, nephrological, oncological 
and cardiological procedures [1–5]. In cardiology, 
the presence of PLSVC is usually incidentally 
detected during placement of pacemakers (PM), 
implantable cardioverter-defibrillators (ICD) and 
cardiac resynchronization therapy (CRT) devices. 
Technical difficulties during lead positioning (espe-
cially ventricular leads) are commonly known and 
often reported in the literature.
The purpose of the present study was to 
describe the methods and evaluate the efficacy of 
permanent PM implantation, and to analyze the 
incidence and treatment of complications in this 
group of patients.
Methods
We performed a single-center retrospective 
analysis of 11 patients (7 women and 4 men, mean 
age 60.4 ±13 years) with PLSVC hospitalized 
between 2000 and 2012 for PM implantation or 
replacement. Patients were included if they had 
PLSVC confirmed before procedure. In the past, 
preoperative venous angiography was frequently 
utilized before lead insertion and in all presented 
patients diagnosis was establish during lead im-
plantation. An atypical guide-wire route (or distal 
part of lead inserted via cephalic vein) course along 
left spine shadow suggested PLSVC presence. 
In this situation venous angiography served to 
exclude arterial route. All of the persons included 
represented indications to different interventions: 
2 patients required transvenous lead extraction 
(TLE) due to electrotherapy complications, the 
next 6 were qualified to implantation or upgrading 
systems, in another 3 patients with diagnosis of 
dilated cardiomyopathy the necessity of implan-
tation ICD or CRT systems was confirmed. In all 
these patients anatomy of the veins of the thorax, 
technical problems with lead implantation in the 
right heart chambers, technical solutions obviating 
anatomically difficult areas and the presence of 
pacing complications and failure were evaluated. 
The details were demonstrated in Table 1.
The study was approved by the local bioethical 
committee and all patients gave their informed 
consent.
130 www.cardiologyjournal.org
Cardiology Journal 2014, Vol. 21, No. 2
Table 1. Baseline characteristics of the patients.
Patients Age  
[years]
Gender Indications for  
PM/ICD/CRT  
implantation
Anatomical  
variant
Type of  
pacing
Interesting
1 82 M Chronic AF  
with AVB  
III degree
Double (paired) 
VCS; favorable  
angle CS/TV
VVI on the right 
side; TLE with  
re-implantation  
to the left side due 
to pocket infection
Easy new RV lead 
placement
2 65 F Dilated  
cardiomyopathy, 
LVEF 30%, LBBB
Double (paired) 
VCS; favorable 
angle CS/TV; inac-
cessible CS branch
CRT-D Necessity of  
epicardial LV lead 
placement during 
another procedure
3 76 F SSS, AVB  
II degree
Probably double 
(paired) VCS; favo-
rable angle CS/TV; 
visible CS branch
AAI — upgrading  
to DDD
There was a not 
applied chance for 
more favorable  
LV pacing
4 55 F Artificial mitral  
valve, brady- 
-tachycardia  
syndrome with 
SSS, developing  
chronic AF
Probably single 
(very large CS)  
venography done 
but not recorded
AAI — upgrading 
to VVI
Selection pacing  
of LA as the first 
choice and  
abandonment  
idea for RA pacing
5 60 F SSS with  
brady-tachycardia  
syndrome and  
inter-atrial block
Single (description 
of venography)
Bi-atrial pacing Straight lead pace 
lateral wall of RA 
but J-shaped lead 
— excellently we-
dged in enlarged CS
6 52 F SSS, potential AV 
conduction  
disorders  
(Wenckebach  
point 120/min);  
paroxysmal AF
Probably double  
but implantation 
right side system  
in another
DDD Selection pacing  
of LA as the first 
choice and easy 
new RV lead
7 54 M Dilated  
cardiomyopathy, 
LVEF 30%, LBBB
Probably single 
(more central  
course of VCS)  
venography was 
not done
CRT-P Very easy LV lead 
implantation and  
its stable position
8 35 M Dilated  
cardiomyopathy, 
LVEF 20%,  
non-sustained VT
Single PLSVC,  
extreme  
non-favorable  
angle CS/TV
ICD Impossibility to 
pass from CS to RV, 
ICD lead location in 
mid cardiac vein
9 56 F AVB II degree Single PLSVC,  
non-favorable angle 
CS/TV, difficult  
anatomy
DDD It was necessary  
to create of the 
ventricular lead 
loop, in RA to pass  
tricuspid valve
10 52 M AVB III degree Double (paired)  
VCS
DDD — TLE due 
to dysfunction of 
the leads with re-
-implantation on  
the right side
Selection of the 
simplest solution  
— right side  
system  
implantation
11 78 F SSS with  
brady-tachycardia 
syndrome and  
AVB I degree 
Single VCS;  
favorable  
angle CS/TV
DDD Only one case  
where both leads 
were located in 
selected but not in 
constrained places
AF — atrial fibrillation; AVB — atrio-ventricular block; CS — coronary sinus; CRT — cardiac resynchronization therapy; F — female;  
ICD — implantable cardioverter-defibrillator; LA — left atrium; LBBB — left bundle branch block; LVEF — left ventricular ejection fraction; 
LV — left ventricle; M — male; PM — pacemaker; PLSVC — persistent left superior vena cava; RA — right atrium; RV — right ventricle; 
SSS — sick sinus syndrome; TLE — transvenous lead extraction; VCS — vena cava superior; TV — tricuspid valve; VT — ventricular  
tachycardia
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Results
The study population consisted of 7 women 
and 4 men, mean age of 60.4 ± 13 years, with 
indications for PM implantation due to sick sinus 
syndrome (SSS) (4 patients), dilated cardiomy-
opathy with left bundle branch block (2 patients) 
or ventricular tachycardia episodes (1 patient), 
and atrio-ventricular (AV) blocks (4 patients). The 
patients received pacing devices in accordance with 
the indications found (Table 1).
After over 12 years of follow-up 4 patients 
developed complications that necessitated lead re- 
-implantation (patients no. 1 and 10) or lead repla-
cement/pacing mode switch (patients no. 3 and 4). 
Patient number 1 developed pocket infection on 
the right side of the chest at 5 years after VVI 
implantation and according to the I class of Heart 
Rhythm Society consensus — was selected for 
TLE [6]. During the procedure the patient required 
temporary cardiac pacing (temporary pacing lead 
was introduced via the femoral vein). The lead 
was liberated using a pair of green Byrd dilators 
(Cook®). TLE procedure was difficult because the 
lead was strongly grown into the right ventricle 
wall. Nevertheless, TLE run without complica-
tions and any specific tools or actions weren’t 
used. During implantation of a new PM on the left 
side of the chest an anatomical anomaly (PLSVC) 
was found. Left ventricular pacing failed (phrenic 
nerve stimulation through only one accessible 
great vein); however, it was possible to pass the 
lead through the right atrium to the right ventricle, 
and the right ventricular lead was successfully re-
-implanted (Fig. 1).
In patient number 3 with an atrial lead im-
planted via a PLSVC 6 years before due to SSS it 
was necessary to switch the pacing mode to DDD 
due to paroxysmal 2nd degree AV block. Because 
of potential problems with vascular access, prior 
to the procedure venography was performed, 
which revealed normal flow in the PLSVC. Right 
ventricular lead was successfully inserted via the 
PLSVC emptying into the coronary sinus (CS) at 
a convenient angle relative to the tricuspid valve, 
although hemodynamically more favorable left 
ventricular pacing could be taken into account.
Patient number 4 developed brady-tachycardia 
syndrome at 3 years after mitral valve implanta-
tion. In 2001 left atrial lead was inserted via the 
PLSVC and positioned in the CS, which resulted 
in suppression of atrial arrhythmias. Eleven years 
Figure 1. Infected VVI pacemaker implanted in the right side of the chest (A, B). The device was extracted using 
temporary pacing via femoral approach. Persistent left superior vena cava was found during implantation of a new 
system. First attempt to use the coronary sinus branch for left ventricular pacing failed but conventional right ventri-
cular pacing proved easy (C, D).
Figure 2. Mechanical mitral valve and severe brady-tachycardia syndrome. Permanent (enlarged) coronary sinus 
ostium pacing as the simplest method of atrial resynchronization. Much more “symmetrical” atrial activation than 
during lateral wall right atrium pacing.
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later the patient developed acute prosthetic valve 
thrombosis and permanent atrial fibrillation. The 
patient was selected for cardiac surgery with 
re-implantation of prosthetic valve. During the 
operation right ventricular pacing was achieved by 
positioning an epicardial ventricular lead, whereas 
left atrial lead was extracted transvenously later 
on (Fig. 2).
In patient number 10 symptoms of lead dysfun-
ction developed at 6 years after DDD implantation. 
Patient complained about weakness and presyn-
cope. During PM control the increase of ventricle 
lead resistance with periodical ineffectual pacing 
were revealed and the man was qualified for TLE 
with re-implantation of the new system. TLE was 
performed using the inner elastic yellow sheath 
of the Byrd dilator (Cook®). The procedure took 
place without complications, although the leads 
were already strongly rooted in the heart walls. 
Afterwards, the leads were re-implanted via the 
right superior vena cava (RSVC) and positioned 
in the right atrium and the right ventricle (Fig. 3).
Patients number 2 and 7, because of dilated 
cardiomyopathy with cardiac asynchrony, were 
selected for CRT. In patient number 2 due to 
technical difficulties (marked enlargement of the 
CS) it was not possible to insert a pacing lead into 
the left ventricle via the PLSVC. Instead, a right 
atrial lead was placed in the right atrium, whereas 
a defibrillation lead with the entire CRT-D device 
was placed in the right ventricle. Then, an epicar-
dial left ventricular screw-in lead was implanted 
via left mini-thoracotomy (Fig. 4).
Patient number 7 received a CRT-P device in 
2002 with successful implantation of 3 leads via the 
PLSVC with left ventricular lead insertion being 
the easiest stage of the procedure.
Patient number 8 developed recurrent hemo-
dynamically destabilizing ventricular tachycardia 
that necessitated implantation of an ICD. Venogra-
phy prior to the procedure revealed absent RSVC. 
Because of the very inconvenient angle of the 
enlarged coronary ostium relative to the tricuspid 
valve 2 attempted insertions of the defibrillator 
lead via the PLSVC were unsuccessful. A third 
attempt was made, this time to insert the lead into 
the ostium of the middle cardiac vein, achieving 
efficient control/pacing/defibrillation.
Patients number 5, 6, 9 and 11 required double 
lead PM. Patient number 5 due to inter-atrial con-
duction disorders received a ventricular straight 
lead in the right atrium and a J-shaped lead in the 
CS, which resulted in effective low-threshold bi-
-atrial pacing (Fig. 5). In patient number 6 with 
indications for DDD implantation an atrial pacing 
lead was placed in the CS ostium to achieve the 
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Figure 3. Successful DDD system implantation in spite of difficult anatomy. A ventricular lead loop in right atrium 
(RA) was created to pass the lead effectively through the tricuspid valve (A, B, C, D). The system has been working 
perfectly for nearly 3 years but both leads are located in a less favorable site (lateral and anterior RA wall). X-ray chest 
PA view seemed to indicate a possibility of passing the lead via persistent foramen ovale or atrial septal defect to the 
left ventricular lumen (A) but another examination excluded this option.
Figure 4. Implantation of a CRT-D device in a patient with double superior vena cava (A). Persistent left superior vena 
cava was connected with coronary sinus (CS) near the CS ostium (B); implantation of right atrium and right ventricle 
(implantable cardioverter-defibrillator) leads was easy but no CS branch was found. The patient received epicardial 
left ventricular lead implanted by left-sided mini thoracotomy several weeks later (C).
Figure 5. A, B. Still working bi-atrial pacing system for atrial resynchronization due to brady-tachycardia syndrome 
with severe inter-atrial block implanted 12 years before. Conventional straight lead for lateral wall right atrium pacing 
(unfavorable site from the electrophysiological viewpoint), but J-shaped lead was excellently wedged in enlarged 
coronary sinus enabling fine atrial resynchronization.
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antiarrhythmic effect of left atrial pacing, whereas 
a right ventricular lead was positioned in the typical 
site (Fig. 6). Patients number 9 and 11 received 
typical DDD devices (right atrial and right ventri-
Figure 6. A, B, C. Implantation of a DDD pacing system. Atrial lead paces enlarged coronary sinus (CS) (left atrium). 
Implantation of right ventricle lead was relatively easy due to favorable angle of CS ostium relative to tricuspid valve. 
CS pacing as an interesting alternative for lateral wall right atrium pacing. 
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cular leads), however due to extremely different ana-
tomical conditions and technical difficulties, the final 
positions of the leads were entirely different (Fig. 7).
After 12 years of follow-up the survival is 
90.9% (the actual fate of patient no. 7 with the 
CRT-P device remains unknown), with significant 
PM-related problems i.e. increases in defibrillation 
threshold detected in 1 patient — number 8. How-
ever, no further intervention has been attempted 
and the patient is waiting for a heart transplant.
Discussion
PLSVC is a remnant of a vessel that is present 
in early embryological development. Initially, 
2 symmetrical cardinal veins (right and left) form 
the main venous drainage system of the embryo. 
By the 8th week of gestation the innominate vein 
connects the right and left anterior cardinal veins. 
The cephalic portion of superior cardinal veins form 
the internal jugular veins while the right anterior 
and common cardinal veins form the RSVC. The 
part of the left anterior cardinal vein caudal to the 
innominate vein normally regresses to become the 
ligament of Marshall. Failure of this regression is 
attributed to the formation of a PLSVC. The inno-
minate vein may regress, but frequently it remains 
as another anatomical variant of the venous dra-
inage [7]. PLSVC most frequently coexists with 
a normal RSVC, the distal part of the RSVC rarely 
regresses, which means that the PLSVC drains 
the caudal parts. Anatomical variants of PLSVC 
are significant from the clinical viewpoint — in 
80–90% of cases the PLSVC drains into the right 
atrium (directly or through the CS), in the rema-
ining 10–20% cases into the left atrium causing 
right-to-left shunt [8].
PLSVC has various practical implications and 
permanent PM/ICD/CRT placement can be challen-
ging. The atypical venous flow is most often detec-
ted during implantation procedure. The operator’s 
problem is to introduce the lead to the right side of 
the chest — it spontaneously moves down along 
the left side of the spine. It is very important to 
perform venous angiography — the visualization 
of PLSVC confluence with assessment of the angle 
of the most often orifice to the CS and possible do-
uble cava vein presence confirmation. Thereafter, 
according to the operator’s experience, the leads 
could be implanted via PLSVC into right atrium and 
via right atrium and tricuspid valve — into right 
ventricle (often using specific tools). Less expe-
rienced operators more often implant the system 
at the opposite chest side after following right-side 
Figure 7. Patient with a DDD system serving for 6 years and dysfunction of both leads (A, B). Another favorable ana-
tomical variant — double (paired) superior vena cava (C). Both leads were extracted and a new pacing system was 
implanted via the right superior vena cava, as easier for upgrading or lead extraction in the future (D).
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venous angiography, if anatomical conditions make 
it possible. The difficulties during implantation and 
helpful specific instruments are often described 
in the literature [9–12]. Experienced operators 
select more favorable electrophysiological and he-
modynamic solutions: epicardial left heart pacing/ 
/sensing and very exceptionally — defibrillation. 
Currently, the first reports about this strategy have 
been published [13]. In the present study, a very 
experienced operator tried to perform the best 
options, individually adjusted to every patient. Ad-
ditionally, currently presented PLSVC population 
is specific because of repeated procedures due to 
late electrotherapy complications or necessity to 
upgrade the system. In the present study there 
were important complications of permanent pacing 
(patient no. 1 — PM pocket infection and patient 
no. 10 — lead dysfunction) that necessitated TLE 
with re-implantation due to limited venous access. 
Late electrotherapy and TLE complications in 
PLSVC patients have not been found in the ava-
ilable literature, however they may be expected 
to occur increasingly frequently. Most problems 
should be encountered in patients with extremely 
tortuous double-coil defibrillator leads placed in 
the right ventricle. The need to change pacing 
mode in patients with PLSVC (patients no. 3 and 
4) poses another challenge. As in patients with 
pacing complications venous angiography should 
be performed to determine venous patency after 
lead insertion and to visualize alternative routes of 
pacing. Changes in pacing mode in single patients 
with PLSVC, as in patient number 3, have been 
found successful after a thorough examination of 
venous drainage [14, 15]. Cardiac surgery may offer 
the opportunity to sew on an epicardial lead as in 
patient number 4. Epicardial lead placement is also 
recommended in patients with low left ventricular 
ejection fraction in whom CRT is indicated but 
insertion of a left ventricular lead via a PLSVC is 
challenging, in spite of the fact that perioperative 
risk is extremely high in these patients, and sur-
gical technique may make it difficult to position 
the lead with suboptimal resynchronization [16, 
17]. In the present study, patient number 2 un-
derwent a hybrid procedure, namely transvenous 
implantation of a right atrial and right ventricular 
lead combined with epicardial placement of a left 
ventricular lead, achieving a spectacular clinical im-
provement due to effective resynchronization. The 
same approach was reported in a group of patients 
with PLSVC [18]. However, CRT implantation in 
patients with PLSVC is not always a challenge. 
Reports of successful CRT procedures using va-
rious diagnostic techniques have been published 
for many years [16, 19–22]. In the present study, 
patient number 7 underwent a successful CRT 
implantation in 2002. It is important to know that 
in a large funnel-shaped sinus it is not possible 
to perform selective venography and create the 
pressure that propels a contrast dye with blood to 
the cardiac veins. Both visualization of vein orifice 
and insertion of the lead in one of the cardiac veins 
on the posterior or lateral myocardial wall is largely 
a matter of chance.
Another important issue in patients with 
PLSVC and high risk of sudden cardiac death is 
the appropriate insertion of a defibrillator lead to 
achieve low defibrillation threshold. Some evidence 
show that in such patients pulse generators should 
be implanted in the left side of the chest to create 
an optimal electric field [23]. Most investigators 
recommend single-coil leads to exclude potential 
displacement of the coils, which is more likely to 
occur in patients with PLSVC. However, with the 
availability of telemetry to change the configuration 
of defibrillators it is possible to use double-coil 
leads [18, 24]. In the present study, placement of 
a defibrillator lead in patient number 8 was very 
difficult because of absent RSVC and anatomically 
unfavorable ostium of the enlarged CS. The only 
possible solution was insertion of the lead into the 
ostium of the middle cardiac vein to achieve effecti-
ve defibrillation. The patient received a double-coil 
lead to improve defibrillation of the posterior wall 
of the enlarged myocardium.
The remaining 2 cases in the present study 
are apparently simple examples of pacing device 
implantation. Patient number 5 with SSS developed 
inter-atrial conduction disorders and a decision was 
made to use bi-atrial pacing, so far not applied in 
patients with PLSVC. Of interest is skillful use 
of a ventricular straight lead in the lateral wall 
of the right atrium and a J-shaped lead in the CS 
to achieve low threshold pacing (the procedure 
was performed during the time when screw-in 
leads were not available in Poland). A similarly 
interesting example of atrial lead placement can 
be seen in patient number 6. A screw-in lead in 
the CS wall resulted in effective left atrial pacing 
with an antiarrhythmic effect. Long-term effec-
tive left atrial pacing in patient number 4 is also 
worth mentioning. All these examples show that 
problems resulting from difficult access to right-
-sided cardiac chambers and also — or first of all 
— potential proarrhythmic and hemodynamically 
unfavorable pacing of the lateral wall of the right 
atrium can be avoided.
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In brief
Patients with PLSVC are a very heteroge-
neous group with different anatomic conditions, 
therefore individualization of therapy is required. 
Technical problems with implantation of complex 
devices may make it difficult to use appropriate 
pacing mode, and in case of difficult access to the 
right heart, left atrial or left ventricular pacing via 
a lead inserted in the CS appears to be an interesting 
therapeutic option.
Epicardial pacing should be considered in 
case of difficulties in transvenous placement of 
the lead.
Because of an increasing number of electrothe-
rapy complications, these problems are also pre-
sent in PLSVC patients and may cause difficulties 
in TLE with re-implantation of a pacing system in 
case of limited venous access. For this reason 
a thorough evaluation of the venous system is re-
quired in PLSVC patients before re-intervention 
to reduce the risk of further complications.
Conclusions
1. PLSVC is present in about 0.3–0.5% of the 
patients selected for implantation of a PM/ 
/ICD/CRT device.
2. PLSVC frequently (5/11 cases) coexists with 
a normal RSVC.
3. PLSVC most frequently (in all 11 patients) 
is emptying into the enlarged CS, while the 
CS orifice relative to the tricuspid valve may 
be at an inconvenient angle, thus limiting the 
possibility of passing the lead through the 
tricuspid valve.
4. Right atrial pacing in patients with PLSVC is 
limited to the lateral wall of the atrium.
5. PLSVC provides an opportunity for transve-
nous left ventricular pacing.
6. Extraction of grown-in right ventricular leads 
inserted via PLSVC may pose a new challenge 
in the future.
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